Publikationen Prof. Dr. med. Peter J. Wild


Seoane M, Buhs S, Iglesias P, Strauss J, Puller AC, Müller J, Gerull H, Feldhaus S, Alawi M, Brandner JM, Eggert D, Du J, Thomale J, Wild PJ, Zimmermann M, Sternsdorf T, Schumacher U, Nollau P, Fisher DE, Horstmann MA (2018) Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair. Oncogene.

IF 6.854


Keller EX, Bachofner J, Britschgi AJ, Saba K, Mortezavi A, Kaufmann B, Fankhauser CD, Wild P, Sulser T, Hermanns T, Eberli D, Poyet C (2018) Prognostic value of unifocal and multifocal positive surgical margins in a large series of robot-assisted radical prostatectomy for prostate cancer. World J. Urol.

IF 2.981


Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U (2018) DNA hypermethylation within TERT promoter upregulates TERT expression in cancer. J. Clin. Invest. 129:223-229.

IF 13.250


Leão R, Lee D, Figueiredo A, Hermanns T, Wild P, Komosa M, Lau I, Mistry M, Nunes NM, Price AJ, Zhang C, Lipman T, Poyet C, Valtcheva N, Oehl K, Coelho H, Sayyid R, Gomes AM, Prado E Castro L, Sweet J, Vinagre J, Apolónio J, Stephens D, Faleiro I, Fadaak K, Richard PO, Kulkarni G, Zlotta AR, Hamilton RJ, Castelo-Branco P, Tabori U (2018) Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer. Int. J. Cancer. 144:1676-1684.

IF 5.444


Rulle U, Tsourti Z, Casanova R, Deml KF, Verbeken E, Thunnissen E, Warth A, Cheney R, Sejda A, Speel EJ, Madsen LB, Nonaka D, Navarro A, Sansano I, Marchetti A, Finn SP, Monkhorst K, Kerr KM, Haberecker M, Wu C, Zygoura P, Kammler R, Geiger T, Gendreau S, Schulze K, Vrugt B, Wild P, Moch H, Weder W, Ciftlik AT, Dafni U, Peters S, Bubendorf L, Stahel RA, Soltermann A (2018) Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort. J. Thorac. Oncol. 13:1851-1863.

IF 10.336


Arvaniti E, Fricker K S, Moret M, Rupp N, Hermanns T, Fankhauser C, Wey N, Wild P J, Rüschoff J H, Claassen M (2018) Automated Gleason grading of prostate cancer tissue microarrays via deep learning. Sci Rep. 8:12054.

IF 4.259


Guo T, Li L, Zhong Q, Rupp N J, Charmpi K, Wong C E, Wagner U, Rueschoff J H, Jochum W, Fankhauser C D, Saba K, Poyet C, Wild P J, Aebersold R, Beyer A (2018) Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers. Life Sci Alliance 1: e201800042.


Zhong Q, Wagner U, Kurt H, Molinari F, Cathomas G, Komminoth P, Barman-Aksözen J, Schneider-Yin X, Rey JP, Vassella E, Rogel U, Diebold J, McKee T, Jochum W, Kashofer K, Hofman P, Zischka M, Moch H, Rechsteiner M, Wild P J (2018) Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing. Pathol. Res. Pract. 214:957-963.

IF 2.994


Brandt L P, Albers J, Hejhal T, Pfundstein S, Gonçalves A F, Catalano A, Wild P J, Frew I J (2018) Mouse genetic background influences whether HrasG12V expression plus Cdkn2a knockdown causes angiosarcoma or undifferentiated pleomorphic sarcoma. Oncotarget. 9:19753-19766.

IF 5.168


Velizheva N P, Rechsteiner M P, Valtcheva N, Freiberger S N, Wong C E, Vrugt B, Zhong Q, Wagner U, Moch H, Hillinger S, Schmitt-Opitz I, Soltermann A, Wild P J, Tischler V (2018) Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study. Pathol. Res. Pract. 214:572-578.

IF 2.994


Rechsteiner M, Dedes K, Fink D, Pestalozzi B, Sobottka B, Moch H, Wild P, Varga Z (2018) Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. J Cancer Res Clin Oncol. 144:865-874.

IF 3.503


Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S (2018) p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urol Oncol. 36:94.

IF 0.818


Oehl K, Kresoja-Rakic J, Opitz I, Vrugt B, Weder W, Stahel R, Wild P, Felley-Bosco E (2018) Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression. Front. Oncol. 8:40.


Erichsen L, Ghanjati F, Beermann A, Poyet C, Hermanns T, Schulz WA, Seifert H H, Wild P J, Buser L, Kröning A, Braunstein S, Anlauf M, Jankowiak S, Hassan M, Bendhack M L, Bravo M A, Santourlidis S (2018) Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis. Sci Rep. 8:3477.

IF 4.259



Fankhauser C D, Schüffler P J, Gillessen S, Omlin A, Rupp N J, Rueschoff J H, Hermanns T, Poyet C, Sulser T, Moch H, Wild P J (2017) Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer. Oncotarget. 9:10284-10293.

IF 5.168


Gonçalves AF, Adlesic M, Brandt S, Hejhal T, Harlander S, Sommer L, Shakhova O, Wild P J, Frew I J (2017) Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells. Nat. Commun. 8:1466.

IF 12.124


Brandt LP, Albers J, Hejhal T, Catalano A, Wild P J, Frew IJ (2017) Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma. PLoS One. 12(10): e0186102.

IF 2.806


Singer J, Ruscheweyh H J, Hofmann AL, Thurnherr T, Singer F, Toussaint NC, Ng C K Y, Piscuoglio S, Beisel C, Christofori G, Dummer R, Hall M N, Krek W, Levesque M, Manz M G, Moch H, Papassotiropoulos A, Stekhoven DJ, Wild P, Wüst T, Rinn B, Beerenwinkel N (2017) NGS-pipe: a flexible, easily extendable, and highly configurable framework for NGS analysis. Bioinformatics (accepted).

IF 7.307


Nørgaard M, Haldrup C, Storebjerg T M, Vestergaard E M, Wild P J, Høyer S, Borre M, Ørntoft T F, Sørensen K D (2017) Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis. Int J Mol Sci. 18(9).

IF 3.226


Shved N, Warsow G, Eichinger F, Hoogewijs D, Brandt S, Wild P, Kretzler M, Cohen CD, Lindenmeyer MT (2017) Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts. Sci. Rep. 7:8576.

IF 4.259


Dai X, Gan W, Li X, Zhang W, Liu S, Zhong Q, Guo J, Zhang J, Chen T, Shimizu K, Beca F